论文部分内容阅读
目的探讨依那普利联合乐卡地平对高血压早期肾损害患者血压控制及肾功能的影响。方法选取94例高血压早期肾损害患者为研究对象,采用随机数字表法将其分为观察组和对照组,每组47例,对照组给予依那普利口服,观察组联合乐卡地平口服。比较两组患者治疗前后血压状况、肾功能指标及治疗效果。结果观察组治疗总有效率(93.67%)明显高于对照组(74.47%);收缩压、舒张压明显低于对照组;肌酐、尿素氮、微量清蛋白明显低于对照组;两组均未发生严重不良反应。结论依那普利联合乐卡地平有助于控制高血压早期肾损害患者的血压,改善其肾功能,提高治疗效果。
Objective To investigate the effects of enalapril combined with lercanidip on blood pressure control and renal function in patients with early renal damage induced by hypertension. Methods Ninety-four patients with early renal hypertension were selected as study subjects, and were divided into observation group and control group by random number table method, with 47 cases in each group. The control group was orally administered with enalapril and the observation group combined with levodipine . The blood pressure, renal function and therapeutic effect were compared between the two groups before and after treatment. Results The total effective rate (93.67%) in the observation group was significantly higher than that in the control group (74.47%); systolic blood pressure and diastolic blood pressure were significantly lower than those in the control group; creatinine, urea nitrogen and microalbumin were significantly lower than those in the control group A serious adverse reaction occurred. Conclusion Enalapril combined with lercanidipine can help control the blood pressure of patients with early renal damage in hypertension, improve their renal function and improve the therapeutic effect.